Literature DB >> 9637724

Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis.

L M Akyürek1, C Johnsson, D Lange, P Georgii-Hemming, E Larsson, B C Fellström, K Funa, G Tufveson.   

Abstract

Based on successful induction of donor-specific unresponsiveness by alloantigenic stimulation in several animal models of acute rejection, we hypothesized that similar immune manipulations would also inhibit the evolution of chronic rejection and transplant vasculopathy. To induce immune tolerance, DA rats received a PVG heart allograft and were immunosuppressed with cyclosporine for 30 d. At day 100 the animals were challenged with a PVG aortic allograft after either 1 or 18 h of cold ischemia. 8 wk after the aortic transplantation, the grafts were investigated for morphological changes, infiltrating cells, apoptosis, and Fas-Fas ligand expression. Control allografts showed advanced transplant arteriosclerosis, whereas tolerance-induced aortic allografts displayed reduced neointimal formation, less medial atrophy, fewer apoptotic cells, and fewer Fas- and FasL-expressing cells. Prolonged ischemic storage time did not profoundly alter the morphological changes of the allografts. Fas expression was found in T cells, macrophages, vascular smooth muscle cells, and endothelial cells, whereas FasL was expressed mainly by T cells and macrophages. FasL mRNA expression was evident throughout the entire allograft wall. In conclusion, induction of allospecific tolerance can effectively prevent transplant arteriosclerosis. Cold ischemia damage does not abrogate the beneficial effect of tolerance, but creates a separate identity of mainly endothelial lesions. Furthermore, Fas-mediated apoptosis appears to be involved in the pathological lesions seen in chronic rejection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637724      PMCID: PMC508881          DOI: 10.1172/JCI1177

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

2.  Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.

Authors:  M S Orloff; E M DeMara; M L Coppage; N Leong; M A Fallon; J Sickel; X J Zuo; J Prehn; S C Jordan
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

3.  Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells.

Authors:  Y J Geng; L E Henderson; E B Levesque; M Muszynski; P Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

4.  Development of chronic injury and nature of interstitial infiltrate in a model of chronic renal allograft rejection.

Authors:  A N Stein-Oakley; P Jablonski; A Tzanidis; K Baxter; B O Howden; V C Marshall; N M Thomson
Journal:  Transplantation       Date:  1993-12       Impact factor: 4.939

5.  The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.

Authors:  J Drappa; N Brot; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.

Authors:  N C Chowdhury; R A Fawwaz; S F Oluwole
Journal:  J Surg Res       Date:  1993-04       Impact factor: 2.192

7.  Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.

Authors:  A Räisänen-Sokolowski; S Yilmaz; G Tufveson; P Häyry
Journal:  Transplantation       Date:  1994-06-27       Impact factor: 4.939

8.  Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia.

Authors:  E G Nabel; L Shum; V J Pompili; Z Y Yang; H San; H B Shu; S Liptay; L Gold; D Gordon; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

9.  Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells.

Authors:  D Leszczynski; Y Zhao; M Luokkamäki; M L Foegh
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

10.  Purification and characterization of the Fas-ligand that induces apoptosis.

Authors:  T Suda; S Nagata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  5 in total

1.  Study of molecular mechanism of Prostaglandin E1 in inhibiting coronary heart disease.

Authors:  H J Liu; J W Ma; Z Y Qiao; B Xu
Journal:  Mol Biol Rep       Date:  2013-10-22       Impact factor: 2.316

2.  Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.

Authors:  D Berglund; M Karlsson; A-R Biglarnia; T Lorant; G Tufveson; O Korsgren; B Carlsson
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

3.  The effects of tolerance on allograft damage caused by the innate immune system.

Authors:  Ruediger Hoerbelt; Christopher L Benjamin; Tsuyoshi Shoji; Stuart L Houser; Ashok Muniappan; Rebecca S Hasse; Levi G Ledgerwood; James S Allan; David H Sachs; Joren C Madsen
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

4.  Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.

Authors:  Kasinath Viswanathan; Ilze Bot; Liying Liu; Erbin Dai; Peter C Turner; Babajide Togonu-Bickersteth; Jakob Richardson; Jennifer A Davids; Jennifer M Williams; Mee Y Bartee; Hao Chen; Theo J C van Berkel; Erik A L Biessen; Richard W Moyer; Alexandra R Lucas
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

5.  Fas induces apoptosis in human coronary artery endothelial cells in vitro.

Authors:  Gerasimos Filippatos; Edmund Ang; Claudia Gidea; Erhan Dincer; Rongqi Wang; Bruce D Uhal
Journal:  BMC Cell Biol       Date:  2004-01-22       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.